Almirall SA
Almirall reported revenue of €14.5m for the 2025 financial year (annual accounts filed with the NBB on 06 May 2026).
The score of Almirall shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +93 % Equity +14 % Total assets +42 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Almirall's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 May 2026
- Year ended 31 Dec 2024filed on 21 May 2025
- Year ended 31 Dec 2023filed on 02 May 2024
- Year ended 31 Dec 2022filed on 26 Apr 2023
- Year ended 31 Dec 2021filed on 27 Apr 2022
Almirall's financial analysis
- Solvency53.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Almirall
Almirall's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.090.131
- VAT number
- BE0403090131
- Peppol
- Registered · 0208:0403090131 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Jan 1968
- Registered office
- 1932 Zaventem
- Latest accounts
- 2025 · filed on 06 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Almirall (SA) has been based in Zaventem since 1968, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €14.5m, a net profit of — and equity of €4.15m. Its solvency stands at 53.5%, above the median of its sector (46.0%).
Companies similar to Almirall
Companies in the same business, of comparable size and area, outside its group.
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- MED Concept Europe Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet €18.7m
- Lundbeck Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €13.7m
- Merck Wholesale of pharmaceutical and medical goods Hoeilaart · balance sheet €26.6m
- Haleon Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €29.4m
- O&M Halyard Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.9m
- Wolf-Safco Wholesale of pharmaceutical and medical goods Overijse · balance sheet €1.25m
- Biogen Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €25.5m
Frequently asked questions about Almirall
What is the revenue of Almirall?
According to the 2025 annual accounts filed with the NBB, the revenue of Almirall amounts to 14,507,934 €.
What is the VAT number of Almirall?
In Belgium, the VAT number is the company number prefixed with BE: BE0403090131 for Almirall, if the company is VAT-registered. Its company number (CBE) is 0403.090.131.
Where is the registered office of Almirall?
According to the CBE register, the registered office of Almirall is in 1932 Zaventem.
What is the equity of Almirall?
At the close of the 2025 financial year, the equity of Almirall amounts to 4,146,130 €, a solvency of 53.5% of total assets.
Who manages Almirall?
The register lists 11 active mandates at Almirall. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Almirall
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →